USFDA gives tentative approval to Lupin’s Dolutegravir and Rilpivirine tablets
The tablets are used to treat HIV infection
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
USFDA approves Prasugrel tablets by Lupin
The product will be manufactured at Lupin’s facility in Goa
Lupin and Exeltis announce reimbursement approval of NaMuscla
Agreement enables sustainable patient access of the only EU-approved treatment for myotonia symptoms
Lupin launches novel fixed-dose triple drug combination Difizma DPI to treat inadequately controlled…
Difizma is the only FDC that has been approved by the Drug Controller General of India (DCGI) for the treatment of inadequately…
Lupin Diagnostics launches regional reference laboratory in Indore
These labs are equipped with qualified clinical experts and automated and streamlined processes
Lupin gets US FDA approval for Brivaracetam Tablets
The product will be manufactured at Lupin’s facility in Nagpur, India
Lupin launches generic joint pain drug in US
The company's product -- Diclofenac Sodium Topical Solution 2% -- is the generic version of Horizon Pharma Therapeutics Pennsaid
Lupin launches Rufinamide Tablets USP in the US
Rufinamide is indicated for the treatment of the symptoms of Lennox-Gastaut Syndrome
Lupin launches Formoterol Fumarate inhalation solution in US
The company tends to market a generic equivalent of Perforomist Inhalation Solution, 20 mcg/2 mL, of Mylan Specialty